SternSKerenATzivoniD. Torsade de pointes: definition, causative factors, and therapy. Experience with sixteen patients. Ann N Y Acad Sci1984; 427: 23–40.
2.
RodenDThompsonKHoffmanBWoosleyR. Clinical features and basic mechanisms of quinidine-induced arrhythmias. J Am Coll Cardiol1986; 8: 73A–8A.
3.
StratmannHKennedyH. Torsades de pointes associated with drugs and toxins: recognition and management. Am Heart J1987; 113: 1470–82.
4.
FreedmanRAndersonKGreenLMasonJ. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol1987; 59: 168–9.
5.
HonigPWoosleyRZamaniKConnerDCantilenaL. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther1992; 52: 231–8.
6.
ChenYGillisRWoosleyR. Block of delayed rectifier potassium current, IK, by terfenadine in cat ventricular myocytes (abstract). J Am Coll Cardiol1991; 17: 140A.
7.
BiglinKEFaraonMSConstanceTDLieh-LaiM. Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin (letter). Ann Pharmacother1994; 28: 282.
8.
RubartMPresslerMLPrideHPZipesDP. Electrophysiological mechanisms in the canine model of erythromycin-associated long QT syndrome. Circulation1993; 88: 1832–44.
9.
McCombJCampbellNClelandJ. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol1984; 54: 922–3.
10.
GuelonDBedockBChartierCHabererJ. QT prolongation and recurrent “torsades de pointes” during erythromycin administration (letter). Am J Cardiol1986; 58: 666.
11.
RezkallaMPochopC. Erythromycin induced torsades de pointes: case report and review of the literature. S D J Med1994; 47: 161–4.
12.
HaefeliWSchoenenbergerRWeissPRitzR. Possible risk for cardiac arrhythmia related to intravenous erythromycin. Intensive Care Med1992; 18: 469–73.
13.
NattelSRangerSTalajicMLemeryRRoyD. Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med1990; 89: 235–8.
